← Leaderboards
Mira Edgerton
State University Of New York At Buffalo
$10,706,336
Attributed
$11,660,703
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $784.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,660,703 · 6
By mechanism
R01$10,887,710 · 4
R21$438,625 · 1
K02$334,368 · 1
Top collaborators
- Paul J Cullen5 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Libuse Anna Bobek$1,674,115
- Andrew Douglas McCall$85,707
- Hann L Norris$90,483
- John C Panepinto$7,710,663
- Maciej Miroslaw Lis$158,500
Others in their field
Top investigators on “Candida Albicans”
- Alexander D Johnson · University Of California San Francisco$23,545,370
- Aaron P Mitchell · La Biomed Res Inst/ Harbor Ucla Med Ctr$20,872,115
- Gavin J Sherlock · Stanford University$18,218,461
- Jay B Jackson · Johns Hopkins University$17,529,470
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$14,524,347
- Gerald R Fink · Whitehead Institute For Biomedical Res$14,278,186
Research focus
Candida AlbicansOralCellsProteinsAntifungal AgentsSalivaOropharyngeal ThrushOral CandidiasisCell WallCandidiasisVirulenceHistidineIn VitroSignal TransductionMutantResponseMediatingCell MembranePeptide HydrolasesOral CavityHistidine-Rich ProteinsMouse ModelImmunocompromised HostHistatin 5
Grant awards (39)
Salivary Zinc modifies Histatin 5 activity towards C. albicans survivor cells and commensalism$402,500
R01 · FY2025 · DE · contact PI
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells$382,375
R01 · FY2025 · DE · contact PI
Salivary Zinc modifies Histatin 5 activity towards C. albicans survivor cells and commensalism$398,840
R01 · FY2024 · DE · contact PI
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells$374,728
R01 · FY2024 · DE · contact PI
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells$381,188
R01 · FY2023 · DE · contact PI
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells$380,000
R01 · FY2022 · DE · contact PI
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3$199,375
R21 · FY2022 · DE · contact PI
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3$239,250
R21 · FY2021 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$397,138
R01 · FY2019 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$397,284
R01 · FY2018 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$382,756
R01 · FY2017 · DE · contact PI
Regulation of Candida albicans Pathogenesis by the Signaling Mucin Msb2$381,747
R01 · FY2017 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$384,213
R01 · FY2016 · DE · contact PI
Regulation of Candida albicans Pathogenesis by the Signaling Mucin Msb2$381,747
R01 · FY2016 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$397,648
R01 · FY2015 · DE · contact PI
Regulation of Candida albicans Pathogenesis by the Signaling Mucin Msb2$381,747
R01 · FY2015 · DE · contact PI
Regulation of Candida albicans Pathogenesis by the Signaling Mucin Msb2$381,747
R01 · FY2014 · DE · contact PI
Regulation of Candida albicans Pathogenesis by the Signaling Mucin Msb2$381,747
R01 · FY2013 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$361,645
R01 · FY2013 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$376,713
R01 · FY2012 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$369,104
R01 · FY2011 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$380,519
R01 · FY2010 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$345,926
R01 · FY2009 · DE · contact PI
Candidacidal Mechanisms of Salivary Histatins$114,782
R01 · FY2009 · DE · contact PI
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$312,671
R01 · FY2008 · DE · contact PI
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$316,149
R01 · FY2007 · DE · contact PI
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$325,591
R01 · FY2006 · DE · contact PI
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$333,427
R01 · FY2005 · DE
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$333,427
R01 · FY2004 · DE
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$196,350
R01 · FY2003 · DE
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS$83,592
K02 · FY2003 · DE
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$196,350
R01 · FY2002 · DE
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS$83,592
K02 · FY2002 · DE
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$196,350
R01 · FY2001 · DE
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$100,000
R01 · FY2001 · DE
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS$83,592
K02 · FY2001 · DE
Supplements to Support Candida DNA Microarray Facilities$250,000
R01 · FY2000 · DE
CANDIDACIDAL MECHANISMS OF SALIVARY HISTATINS$191,301
R01 · FY2000 · DE
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS$83,592
K02 · FY2000 · DE